Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 165
Filtrer
1.
Ann Chir Plast Esthet ; 69(5): 384-390, 2024 Sep.
Article de Anglais | MEDLINE | ID: mdl-39034221

RÉSUMÉ

BACKGROUND: Autologous breast reconstruction is considered high-risk for deep vein thrombosis (DVT) and thromboembolism (PE). It is therefore recommended to treat patients undergoing these complex and lengthy procedures with DVT chemoprophylaxis. The optimal anticoagulation protocol is still not established. The objective of our study was to evaluate the need of a prolonged anticoagulation in patients undergoing microsurgical breast reconstruction. METHODS: This retrospective cohort study compares our former anticoagulation protocol, which was given during the in-hospital stay, with our new protocol consisting of extended anticoagulation until postoperative day 25, in terms of DVT/PE risk reduction. A logistic regression was used to evaluate the risk of DVT/PE between the two groups, while adjusting for several covariates. RESULTS: Our cohort consisted of 205 patients in the short-term anticoagulation group and 219 in the extended protocol group. Five patients (2.4%) in the short-term anticoagulation group had a DVT/PE event versus 4 patients (1.8%) in the extended protocol group. Logistic regression revealed no difference in the incidence of DVT/PE between the two groups. Similarly, there was no differences in terms of hematoma and infection rate between the two groups. Finally, we found an increased risk of DVT/PE in patients with a Caprini score equal or greater than 8. CONCLUSION: In our experience, short-term anticoagulation during the hospital stay is equivalent to extended thromboprophylaxis in terms of DVT/PE prevention.


Sujet(s)
Anticoagulants , Mammoplastie , Thromboembolisme veineux , Humains , Études rétrospectives , Mammoplastie/méthodes , Mammoplastie/effets indésirables , Femelle , Adulte d'âge moyen , Thromboembolisme veineux/prévention et contrôle , Thromboembolisme veineux/étiologie , Anticoagulants/administration et posologie , Anticoagulants/usage thérapeutique , Complications postopératoires/prévention et contrôle , Lambeau perforant/effets indésirables , Adulte , Chimioprévention/méthodes , Calendrier d'administration des médicaments , Thrombose veineuse/prévention et contrôle , Thrombose veineuse/étiologie
2.
J Vet Cardiol ; 43: 61-69, 2022 Oct.
Article de Anglais | MEDLINE | ID: mdl-36030724

RÉSUMÉ

Congenital membranous ventricular septal aneurysm has been reported in dogs and can be associated with a perimembranous ventricular septal defect (VSD). The windsock-like ventricular septal aneurysm is formed by tissue of the membranous ventricular septum and portions of the septal leaflet of the tricuspid valve. We report two dogs that underwent transcatheter closure of perimembranous VSD associated with membranous ventricular septal aneurysm using a commercial device marketed for transcatheter closure of patent ductus arteriosus, the canine duct occluder. Partial closure was achieved in the first dog with reduction in left heart dimensions documented on echocardiography both at one day and nine months after procedure. In the second dog, three-dimensional transesophageal echocardiography, cardiac computed tomography, and a three-dimensionally printed whole heart model were used to evaluate feasibility for transcatheter device closure. Complete closure of the VSD was subsequently achieved. Both cases had good short- to medium-term outcomes, no perioperative complications were observed, and both dogs are apparently healthy and receiving no cardiac medications at 34 months and 17 months after procedure. Transcatheter attenuation of perimembranous VSD with membranous ventricular septal aneurysm is clinically feasible using the canine duct occluder, and multimodal cardiac imaging allows accurate assessment and planning prior to transcatheter intervention for structural heart disease in dogs.


Sujet(s)
Cathétérisme cardiaque , Maladies des chiens , Anévrysme cardiaque , Communications interventriculaires , Dispositif d'occlusion septale , Chiens , Animaux , Cathétérisme cardiaque/méthodes , Cathétérisme cardiaque/médecine vétérinaire , Communications interventriculaires/imagerie diagnostique , Communications interventriculaires/chirurgie , Communications interventriculaires/médecine vétérinaire , Dispositif d'occlusion septale/médecine vétérinaire , Anévrysme cardiaque/imagerie diagnostique , Anévrysme cardiaque/chirurgie , Anévrysme cardiaque/médecine vétérinaire , Échocardiographie transoesophagienne , Résultat thérapeutique , Maladies des chiens/imagerie diagnostique , Maladies des chiens/chirurgie
3.
Ann Chir Plast Esthet ; 67(4): 189-195, 2022 Sep.
Article de Anglais | MEDLINE | ID: mdl-35840458

RÉSUMÉ

INTRODUCTION: Elliptical skin-sparing mastectomy in patients with large or ptotic breasts usually leaves loose mastectomy skin flaps, which need to be either resected or gathered over the DIEP flap. This results in poor control of the breast footprint and under-projected DIEP flaps in a loose mastectomy skin pocket, that tend to slip laterally towards the axilla. We believe that the use of a Wise pattern mastectomy will allow for immediate treatment of these concerns. MATERIALS AND METHODS: A retrospective, uncontrolled analysis of a prospectively-maintained database of patients operated by the five surgeons performing breast reconstructions at the University of Montreal Hospital Centre. Study population was patients with a BMI of over 25 and grade II/III breast ptosis who underwent a Wise pattern mastectomy with immediate DIEP flap reconstruction. Analysis was performed of the complication rates of the technique in the first six months after the surgery. RESULTS: Out of a total of 53 breasts in 44 patients reconstructed with a DIEP flap immediately post Wise pattern mastectomy, we report nine cases of partial mastectomy-flap necrosis not needing revision, five cases of significant mastectomy flap necrosis needing debridement and skin grafting, and two cases of inability to adequately close the Wise pattern intraoperatively after DIEP placement, necessitating retention of DIEP skin in the inferior pole. None of the mastectomy flap complications occurred in irradiated breasts. CONCLUSION: In patients with large or ptotic breasts, the Wise pattern mastectomy before an immediate DIEP reconstruction allows for immediate shaping of the breast by controlling the breast pocket, footprint, and excess skin.


Sujet(s)
Tumeurs du sein , Mammoplastie , Femelle , Humains , Mastectomie , Nécrose , Études rétrospectives , Résultat thérapeutique
4.
J Vet Cardiol ; 41: 70-78, 2022 Jun.
Article de Anglais | MEDLINE | ID: mdl-35248977

RÉSUMÉ

Trifoliate left atrioventricular (AV) valve with common atrioventricular junction is considered part of the spectrum of atrioventricular septal defect. This valve morphology is typically associated with defects in the AV septum resulting in communication at the atrial or ventricular level, but has also been described as an isolated defect in the setting of a common AV junction without AV septal defect. Trifoliate left AV valve exhibits a line of apposition between the bridging leaflets that is directed toward the inlet interventricular septum, distinguishing it from isolated mitral valve cleft in which the orientation of the bridging leaflets are toward the left ventricular outflow tract. The echocardiographic findings of four dogs with trifoliate left AV valve are described; two with intact septal structures and two with large ostium primum defects. Three dogs underwent open surgical repair using different approaches depending on the presence or absence of a septal defect. One of these underwent concurrent surgical repair for right AV valve dysplasia. One dog with intact septal structures underwent interventional closure of a concurrent patent ductus arteriosus. Current terminology associated with trileaflet left AV valve malformations is reviewed.


Sujet(s)
Maladies des chiens , Communications interauriculaires , Communications interventriculaires , Valvulopathies , Animaux , Maladies des chiens/imagerie diagnostique , Maladies des chiens/chirurgie , Chiens , Échocardiographie/méthodes , Échocardiographie/médecine vétérinaire , Malformations des cloisons cardiaques , Communications interauriculaires/imagerie diagnostique , Communications interauriculaires/chirurgie , Communications interauriculaires/médecine vétérinaire , Communications interventriculaires/imagerie diagnostique , Communications interventriculaires/chirurgie , Communications interventriculaires/médecine vétérinaire , Valvulopathies/médecine vétérinaire , Valve atrioventriculaire gauche/chirurgie
5.
J Vet Cardiol ; 36: 105-114, 2021 Aug.
Article de Anglais | MEDLINE | ID: mdl-34192609

RÉSUMÉ

INTRODUCTION: Combining an antiplatelet drug, clopidogrel, with the direct oral Factor Xa inhibitor, apixaban, could provide an effective antithrombotic strategy in dogs. Thus, a limited 3 + 3 phase I dose-escalation clinical trial in healthy dogs was conducted to evaluate bleeding (primary end-point) and pharmacodynamic (PD)/pharmacokinetic (PK) parameters (secondary end-point). ANIMALS: Eleven beagle dogs, median body weight 10.2 kg (9.7-10.9 kg), were enrolled. METHODS: Four doses of apixaban (three dogs/dose) administered for eight days. Clopidogrel dose was fixed at 18.75 mg per os (PO) q 24 h with escalation of apixaban dose at 5 mg PO q 12 h, 5 mg PO q 8 h, 10 mg PO q 12 h, and 10 mg PO q 8 h. Laboratory testing included fecal occult blood, coagulation parameters, Factor X activity, apixaban concentration, platelet aggregometry, and thromboelastography on days 1, 3, and 8. RESULTS: Evidence of bleeding was not observed at any dosage. Dose-dependent changes in PD/PK parameters between baseline and 3 h post-medication were observed including a prolongation of prothrombin time, a prolongation of activated partial thromboplastin time, a decrease of Factor X activity level, and increased apixaban concentration. CONCLUSIONS: The combination of apixaban at a dosage range of approximately 0.5 mg/kg PO q 12 h to 1 mg/kg PO q 8 h and clopidogrel at approximately 1.8 mg/kg PO q 24 h did not cause bleeding over a one-week period in healthy dogs. Clinically relevant changes in PD/PK data occur at all dosage levels. This study provides a starting point for longer-term clinical trials to determine safety and efficacy.


Sujet(s)
Pyrazoles/usage thérapeutique , Pyridones/usage thérapeutique , Animaux , Essais cliniques de phase I comme sujet , Clopidogrel , Chiens , Fibrinolytiques , Préparations pharmaceutiques
6.
Ann Chir Plast Esthet ; 65(4): 277-283, 2020 Jul.
Article de Anglais | MEDLINE | ID: mdl-32493612

RÉSUMÉ

BACKGROUND: The use of hormone therapy (tamoxifen and aromatase inhibitors) has been shown to increase venous thromboembolism. However, while estrogens play a crucial role in wound healing, no study has assessed the impact of tamoxifen or aromatase inhibitors on other postoperative breast reconstruction complications, including infections, necrosis, capsular contracture and seroma. As breast cancer patients undergoing Implants-ADMs breast reconstruction are often receiving hormone therapy, it is unclear whether this increased infection risk is associated with increased infections cases. METHODS: A prospective study was performed on patients undergoing breast reconstruction at an academic institution from 2013 to 2016. Patients were divided by use of hormone therapy at the time of surgery. Complication rates, including infections, necrosis, seroma and hematomas, were compared and analyzed using univariate and logistic regression models. RESULTS: Among a total of 112 patients (183breasts), 58 patients (91 breasts) were receiving hormone therapy and 54 patients (92 breasts) were not. The hormone therapy group had a higher incidence of postoperative mastectomy skin infection (20.7% versus 7.4%; P=0.0447), we didn't find any significant differences in necrosis. CONCLUSIONS: Hormone therapy was associated with a higher incidence of Infections after breast reconstruction with ADMs and implants. The authors propose an individualized approach to the preoperative cessation of tamoxifen or aromatase inhibitors. Immediate breast reconstruction surgery with expander/direct implant and use of acellular dermal matrix: does hormone therapy increases the risk of infection?


Sujet(s)
Derme acellulaire , Tumeurs du sein , Mammoplastie , Tumeurs du sein/chirurgie , Femelle , Hormones , Humains , Mastectomie , Études prospectives , Études rétrospectives
7.
J Vet Cardiol ; 25: 32-40, 2019 Oct.
Article de Anglais | MEDLINE | ID: mdl-31542555

RÉSUMÉ

Pulmonary artery banding (PAB) is a viable but underreported palliative option for hemodynamically significant ventricular septal defect in small animals. A significant challenge associated with PAB is judging the degree of band tightening, which can be further complicated when animals are immature and still growing at the time of PAB. If a pulmonary artery band is overtightened or becomes progressively too tight after surgery, the result can be reversal of shunt flow with potentially devastating consequences. Placement of a band that could be percutaneously dilated using a balloon catheter affords a minimally invasive option for partially or completely relieving the band should it become too tight after PAB. This report describes a surgical technique for placement of a dilatable pulmonary artery band, reviews guidelines for tightening the band, and reports the outcome of three cats undergoing the procedure. All three cats showed evidence of reduced hemodynamic load after PAB for a period of up to three years after PAB.


Sujet(s)
Maladies des chats/chirurgie , Communications interventriculaires/médecine vétérinaire , Artère pulmonaire/chirurgie , Animaux , Chats , Communications interventriculaires/chirurgie , Hémodynamique , Mâle , Équipement chirurgical , Thoracotomie/médecine vétérinaire
8.
J Biol Regul Homeost Agents ; 30(2 Suppl 2): 13-5, 2016.
Article de Anglais | MEDLINE | ID: mdl-27373128

RÉSUMÉ

Cytomegalovirus (CMV) is a DNA virus estimated to infect 70-90% of the world’s population, producing minimal symptoms in immunocompetent hosts. In the immunocompromised host, CMV infection can be potentially fatal, producing systemic or localized forms. We report the case of a 52-year-old female with acquired immunodeficiency virus (AIDS) who presented multiple sacral and perineal ulcers clinically and histopathologically consistent with CMV ulcerations. We discuss the patient’s clinical presentation and histologic findings to remind physicians to consider CMV as a cause for cutaneous and systemic infection in the immunocompromised host.


Sujet(s)
Syndrome d'immunodéficience acquise/complications , Canal anal/anatomopathologie , Infections à cytomégalovirus/complications , Infections à cytomégalovirus/anatomopathologie , Sacrum/anatomopathologie , Ulcère/anatomopathologie , Femelle , Humains , Adulte d'âge moyen
9.
J Biol Regul Homeost Agents ; 30(2 Suppl 2): 39-43, 2016.
Article de Anglais | MEDLINE | ID: mdl-27373133

RÉSUMÉ

A 70-year-old Caucasian male presented to our clinic for a pruritic eruption progressing over several months. He complained of fatigue with a 20-pound weight loss over the past year. On presentation, the patient had browny-yellow to violaceous, purpuric, macular and papular lesions on the legs, arms, lower abdomen and back. Initial biopsy showed an angiocentric infiltrate with a suggestion of intraluminal proliferation; CD31 and Fli-1 positivity suggested either reactive angioendotheliomatosis or an unusual intravascular histiocytosis. Further excisional biopsies demonstrated perivascular collections of cells with ample cytoplasm, prominent nuclear pleomorphism and mitotic activity. The nuclei demonstrated nuclear folding, grooves and indentations. The atypical cells were S100, CD1a and CD56 positive with immunohistochemistry. A diagnosis of Langerhans cell sarcoma (LCS) was made. LCS is a rare, aggressive malignancy that can involve multiple organs including the skin, lymph nodes, lung, bone marrow, spleen, heart, and brain. The skin and lymph nodes are commonly involved, and the cutaneous presentation varies greatly. Immunohistochemistry characteristically shows CD1a and S100 positivity. CD56 expression is uncommon and often portends a poor prognosis. There is no established treatment of LCS due to its rarity. Surgery, radiation, and chemotherapy have been used with varied outcomes. Our patient was treated with prednisone with improvement of cutaneous disease. He did not develop systemic involvement, but died 1.5 years later from complications associated with heart failure. Langerhans cell sarcoma should be considered when faced with an unusual angiocentric infiltrate in which initial immunohistochemical staining results may be misleading.


Sujet(s)
Sarcome à cellules de Langerhans/anatomopathologie , Tumeurs cutanées/anatomopathologie , Sujet âgé , Issue fatale , Défaillance cardiaque/complications , Humains , Sarcome à cellules de Langerhans/complications , Sarcome à cellules de Langerhans/diagnostic , Mâle , Pronostic , Maladies rares/complications , Maladies rares/diagnostic , Maladies rares/anatomopathologie , Tumeurs cutanées/complications , Tumeurs cutanées/diagnostic
10.
J Dairy Sci ; 98(11): 7797-809, 2015 Nov.
Article de Anglais | MEDLINE | ID: mdl-26298749

RÉSUMÉ

The fertility of dairy cows is challenged during early lactation, and better nutritional strategies need to be developed to address this issue. Combined supplementation of folic acid and vitamin B12 improve energy metabolism in the dairy cow during early lactation. Therefore, the present study was undertaken to explore the effects of this supplement on gene expression in granulosa cells from the dominant follicle during the postpartum period. Multiparous Holstein cows received weekly intramuscular injection of 320 mg of folic acid and 10 mg of vitamin B12 (treated group) beginning 24 (standard deviation=4) d before calving until 56 d after calving, whereas the control group received saline. The urea plasma concentration was significantly decreased during the precalving period, and the concentration of both folate and vitamin B12 were increased in treated animals. Milk production and dry matter intake were not significantly different between the 2 groups. Plasma concentrations of folates and vitamin B12 were increased in treated animals. Daily dry matter intake was not significantly different between the 2 groups before [13.5 kg; standard error (SE)=0.5] and after (23.6 kg; SE=0.9) calving. Average energy-corrected milk tended to be greater in vitamin-treated cows, 39.7 (SE=1.4) and 38.1 (SE=1.3) kg/d for treated and control cows, respectively. After calving, average plasma concentration of ß-hydroxybutyrate tended to be lower in cows injected with the vitamin supplement, 0.47 (SE=0.04) versus 0.55 (SE=0.03) for treated and control cows, respectively. The ovarian follicle ≥12 mm in diameter was collected by ovum pick-up after estrus synchronization. Recovered follicular fluid volumes were greater in the vitamin-treated group. A microarray platform was used to investigate the effect of treatment on gene expression of granulosa cells. Lower expression of genes involved in the cell cycle and higher expression of genes associated with granulosa cell differentiation before ovulation were observed. Selected candidate genes were analyzed by reverse transcription quantitative PCR. Although the effects of intramuscular injections of folic acid and vitamin B12 on lactational performance and metabolic status of animals were limited, ingenuity pathway analysis of gene expression in granulosa cells suggests a stimulation of cell differentiation in vitamin-treated cows, which may be the result of an increase in LH secretion.


Sujet(s)
Bovins/métabolisme , Acide folique/administration et posologie , Expression des gènes/effets des médicaments et des substances chimiques , Cellules de la granulosa/métabolisme , Période du postpartum/métabolisme , Vitamine B12/administration et posologie , Acide 3-hydroxy-butyrique/sang , Animaux , Compléments alimentaires , Métabolisme énergétique , Femelle , Injections musculaires/médecine vétérinaire , Lactation/physiologie , Lait/composition chimique
11.
Int Nurs Rev ; 62(1): 54-63, 2015 Mar.
Article de Anglais | MEDLINE | ID: mdl-25664687

RÉSUMÉ

AIM: The aim of this paper was to (1) highlight nursing continuing education as a key initiative for strengthening healthcare delivery in low-resource settings, and (2) provide an example of a nursing continuing education programme in Haiti. BACKGROUND: Haiti and other low-resource settings face extreme challenges including severe shortages of healthcare workers, high rates of nurse out-migration and variations in nurse competency at entry-to-practice. Nursing continuing education has the potential to address these challenges and improve healthcare delivery through enhanced nurse performance and retention; however, it is underutilized in low-resource settings. METHODS: A case study is presented from the Hôpital Universitaire de Mirebalais in Mirebalais, Haiti of a new nursing continuing education programme called the Beyond Expert Program. RESULTS: The case study highlights eight key dimensions of nursing continuing education in low-resource settings: (1) involving local stakeholders in planning process, (2) targeting programme to nurse participant level and area of care, (3) basing course content on local context, (4) including diverse range of nursing topics, (5) using participatory teaching methods, (6) addressing resource constraints in time and scheduling, (7) evaluating and monitoring outcomes, and (8) establishing partnerships. The case study provides guidance for others wishing to develop programmes in similar settings. CONCLUSION: Creating a nursing continuing education programme in a low-resource setting is possible when there is commitment and engagement for nursing continuing education at all levels of the organization. IMPLICATIONS FOR NURSING AND HEALTH POLICY: Our report suggests a need for policy-makers in resource-limited settings to make greater investments in nursing continuing education as a focus of human resources for health, as it is an important strategy for promoting nurse retention, building the knowledge and skill of the existing nursing workforce, and raising the image of nursing in low-resource settings.


Sujet(s)
Programme d'études , Prestations des soins de santé/organisation et administration , Formation continue infirmier/organisation et administration , Personnel infirmier hospitalier/enseignement et éducation , Personnel infirmier hospitalier/ressources et distribution , Compétence clinique , Haïti , Humains , Études de cas sur les organisations de santé , Mise au point de programmes
12.
Horm Metab Res ; 47(9): 681-5, 2015 Aug.
Article de Anglais | MEDLINE | ID: mdl-25502943

RÉSUMÉ

Subclinical hypothyroidism, characterized by an isolated rise in TSH serum levels with normal thyroid function, is a pro-inflammatory state associated with insulin resistance. Adipocytes express TSH receptors, but it is not known if TSH can directly inhibit insulin signaling. Using primary human differentiated adipocytes, we examined the effects of TSH on insulin-stimulated Akt phosphorylation, and whether conventional PKC (cPKC) were involved. The effect of insulin on TSH-stimulated lipolysis was also investigated. TSH inhibited insulin-stimulated Akt phosphorylation in adipocytes by 54%. TSH activated cPKC, and Gö6976, a PKCα and -ß1 inhibitor, prevented the inhibitory effect of TSH on the insulin response. Insulin reduced the ability of TSH to activate cPKC and to stimulate lipolysis.Our data reveal novel interactions between TSH and insulin. TSH inhibits insulin-stimulated Akt signaling in a cPKC-dependent fashion, whereas insulin blocks TSH-stimulated cPKC activity and lipolysis. TSH and insulin act on differentiated human adipocytes to modulate their respective intracellular signals.


Sujet(s)
Adipocytes/métabolisme , Insuline/métabolisme , Protéine kinase C/métabolisme , Transduction du signal/physiologie , Thyréostimuline/métabolisme , Adulte , Différenciation cellulaire , Cellules cultivées , Femelle , Humains , Lipolyse , Mâle , Adulte d'âge moyen
13.
BJOG ; 121(12): 1492-500, 2014 Nov.
Article de Anglais | MEDLINE | ID: mdl-24758368

RÉSUMÉ

OBJECTIVE: To assess disparities in pre-eclampsia and eclampsia among immigrant women from various world regions giving birth in six industrialised countries. DESIGN: Cross-country comparative study of linked population-based databases. SETTING: Provincial or regional obstetric delivery data from Australia, Canada, Spain and the USA and national data from Denmark and Sweden. POPULATION: All immigrant and non-immigrant women delivering in the six industrialised countries within the most recent 10-year period available to each participating centre (1995-2010). METHODS: Data was collected using standardised definitions of the outcomes and maternal regions of birth. Pooled data were analysed with multilevel models. Within-country analyses used stratified logistic regression to obtain odds ratios (OR) with 95% confidence intervals (95% CI). MAIN OUTCOME MEASURES: Pre-eclampsia, eclampsia and pre-eclampsia with prolonged hospitalisation (cases per 1000 deliveries). RESULTS: There were 9,028,802 deliveries (3,031,399 to immigrant women). Compared with immigrants from Western Europe, immigrants from Sub-Saharan Africa and Latin America & the Caribbean were at higher risk of pre-eclampsia (OR: 1.72; 95% CI: 1.63, 1.80 and 1.63; 95% CI: 1.57, 1.69) and eclampsia (OR: 2.12; 95% CI: 1.61, 2.79 and 1.55; 95% CI: 1.26, 1. 91), respectively, after adjustment for parity, maternal age and destination country. Compared with native-born women, European and East Asian immigrants were at lower risk in most industrialised countries. Spain exhibited the largest disparities and Australia the smallest. CONCLUSION: Immigrant women from Sub-Saharan Africa and Latin America & the Caribbean require increased surveillance due to a consistently high risk of pre-eclampsia and eclampsia.


Sujet(s)
Pays développés , Éclampsie/ethnologie , Émigrants et immigrants , Disparités de l'état de santé , Pré-éclampsie/ethnologie , Adulte , Afrique subsaharienne/ethnologie , Australie/épidémiologie , Canada/épidémiologie , Caraïbe/ethnologie , Bases de données factuelles , Europe/épidémiologie , Extrême-Orient/ethnologie , Femelle , Humains , Amérique latine/ethnologie , Durée du séjour/statistiques et données numériques , Modèles logistiques , Adulte d'âge moyen , Grossesse , États-Unis/épidémiologie
14.
Ann Chir Plast Esthet ; 59(1): 9-14, 2014 Feb.
Article de Français | MEDLINE | ID: mdl-24210968

RÉSUMÉ

STUDY OBJECTIVE: In 2007, the WHO adopted surgical safety as the theme for the 2nd global patient safety challenge. Measurement of surgical services was identified as a surgical care area in need of major improvements. Aware of this recommendation, a preliminary study was conducted in our hospital and showed that the incidence of complete necrosis in free flap surgery was 10.0 %, a rate among the highest found in medical literature. In that context, an interactive surgical follow-up platform (PICS) was implemented to monitor outcomes in free flap surgery. The hypothesis was to reduce the short-term failure of microsurgical reconstructions. PATIENTS AND METHODS: In Summer 2010, the tool for capturing and analyzing data (PICS) was implemented. All patients who underwent free flap reconstruction were prospectively registered in the platform. The primary endpoints to evaluate the effectiveness of the tool are the rates of surgical re-exploration and complete necrosis of the flap. RESULTS: From May 2010 to December 2011, 129 cases of free flap reconstruction were recorded. The rate of total flap necrosis was 10.0 % before database introduction and declined to 3.1 % afterwards (P<0.05). Take-backs occurred in 27.0 % of free flap reconstructions at baseline and in 10.1 % after implementation (P<0.01). CONCLUSION: The implementation of PICS is associated with a significant improvement of postoperative short-term outcomes in free flap surgery. This tool is effective to evaluate care services and provides an increased surgical safety for patients. Surgical teams are encouraged to implement a data collection tool in order evaluate operative care on a routine basis.


Sujet(s)
Bases de données factuelles , Lambeaux tissulaires libres , Complications postopératoires/prévention et contrôle , Études de cohortes , Études de suivi , Humains , Complications postopératoires/étiologie , Études rétrospectives
15.
Ultrasound Obstet Gynecol ; 43(1): 106-7, 2014 Jan.
Article de Anglais | MEDLINE | ID: mdl-24323976
16.
Matern Child Health J ; 17(5): 816-36, 2013 Jul.
Article de Anglais | MEDLINE | ID: mdl-22714797

RÉSUMÉ

Our objectives were to determine whether migrant women in Western industrialized countries have higher odds of inadequate prenatal care (PNC) compared to receiving-country women and to summarize factors that are associated with inadequate PNC among migrant women in these countries. We conducted searches of electronic databases (MEDLINE, EMBASE, and PsycINFO), reference lists, known experts, and an existing database of the Reproductive Outcomes And Migration international research collaboration for articles published between January, 1995 and April, 2010. Title and abstract review and quality appraisal were conducted independently by 2 reviewers using established criteria, with consensus achieved through discussion. In this systematic review of 29 studies, the majority of studies demonstrated that migrant women were more likely to receive inadequate PNC than receiving-country women, with most reporting moderate to large effect sizes. Rates of inadequate PNC among migrant women varied widely by country of birth. Only three studies explored predictors of inadequate PNC among migrant women. These studies found that inadequate PNC among migrant women was associated with being less than 20 years of age, multiparous, single, having poor or fair language proficiency, education less than 5 years, an unplanned pregnancy, and not having health insurance. We concluded that migrant women as a whole were more likely to have inadequate PNC and the magnitude of this risk differed by country of origin. Few studies addressed predictors of PNC utilization in migrant women and this limits our ability to provide effective PNC in this population.


Sujet(s)
Prise en charge prénatale/statistiques et données numériques , Population de passage et migrants , Pays développés , Femelle , Enquêtes sur les soins de santé , Disparités de l'état de santé , Humains , Parité , Grossesse , Qualité des soins de santé
17.
Horm Metab Res ; 44(11): 825-31, 2012 Oct.
Article de Anglais | MEDLINE | ID: mdl-22730012

RÉSUMÉ

Adipocytes express TSH receptors, and TSH can stimulate cAMP-dependent protein kinase, perilipin phosphorylation, and lipolysis in human and mouse 3T3-L1 adipocytes. TSH activates PKC in thyrocytes. Since PKC has been implicated in lipolysis in adipocytes, we examined whether the family of conventional isoforms of PKC (cPKC) is a target of TSH in adipocytes, and whether cPKC is required for TSH-stimulated lipolysis. Differentiated 3T3-L1 and subcutaneous abdominal human adipocytes in culture were treated with TSH in the presence or absence of either PKC inhibitor Gö6976 (inhibits PKCα, ßI) or Gö6983 (inhibits PKCα, ßI, ßII, γ, δ). Activation of cPKC was assessed by phospho-(ser) PKC substrate antibody immunoblot analysis. Perilipin phosphorylation was measured by SDS-PAGE electromobility shift followed by anti-perilipin immunoblot analysis. Lipolysis was quantified by the amount of nonesterified fatty acids (NEFAs) released into the medium. TSH strongly and significantly activated cPKC in differentiated human and 3T3-L1 adipocytes from undetectable levels in control conditions. This cPKC stimulation in human adipocytes by TSH was reduced significantly by 40% or 48% in the presence of PKC inhibitor Gö6983 or Gö6976, respectively. Gö6976 inhibited TSH-stimulated human adipocyte perilipin phosphorylation and NEFA release by 80% and 50%, respectively. We conclude that cPKC is activated by TSH in human differentiated adipocytes. Based on the effects of cPKC inhibition, cPKC activation is required for TSH-stimulated perilipin phosphorylation and lipolysis in human differentiated adipocytes.


Sujet(s)
Protéines de transport/métabolisme , Lipolyse , Phosphoprotéines/métabolisme , Protéine kinase C/métabolisme , Thyréostimuline/métabolisme , Adipocytes/enzymologie , Adipocytes/métabolisme , Adulte , Animaux , Protéines de transport/génétique , Différenciation cellulaire , Cellules cultivées , Activation enzymatique , Femelle , Humains , Mâle , Souris , Adulte d'âge moyen , Périlipine-1 , Phosphoprotéines/génétique , Phosphorylation , Protéine kinase C/génétique
18.
Mol Ecol Resour ; 11(6): 1022-32, 2011 Nov.
Article de Anglais | MEDLINE | ID: mdl-21749673

RÉSUMÉ

Intraguild predation (IGP) has been increasingly recognized as an important interaction in ecological systems over the past two decades, and remarkable insights have been gained into its nature and prevalence. We have developed a technique using molecular gut-content analysis to compare the rate of IGP between closely related species of coccinellid beetles (lady beetles or ladybirds), which had been previously known to prey upon one another. We first developed PCR primers for each of four lady beetle species: Harmonia axyridis, Coccinella septempunctata, Coleomegilla maculata and Propylea quatuordecimpunctata. We next determined the prey DNA detection success over time (DS(50) ) for each combination of interacting species following a meal. We found that DS(50) values varied greatly between predator-prey combinations, ranging from 5.2 to 19.3 h. As a result, general patterns of detection times based upon predator or prey species alone are not discernable. We used the DS(50) values to correct field data to demonstrate the importance of compensation for detection times that are specific to particular predator-prey combinations.


Sujet(s)
Coléoptères/génétique , Chaine alimentaire , Contenus gastro-intestinaux/composition chimique , Comportement prédateur/physiologie , Animaux , Coléoptères/physiologie , Amorces ADN/génétique , Réaction de polymérisation en chaîne , Spécificité d'espèce , Facteurs temps
19.
J Pediatr Urol ; 7(1): 83-5, 2011 Feb.
Article de Anglais | MEDLINE | ID: mdl-21050823

RÉSUMÉ

Respiratory distress due to urinary tract obstruction can be a urologic emergency. We describe the diagnostic and surgical management of severe respiratory distress in a neonate due to a crossed ectopic obstructed megaureter in a duplicated pelvic kidney.


Sujet(s)
Choristome/chirurgie , Décompression chirurgicale , Maladies du rein/complications , Rein/malformations , Insuffisance respiratoire/étiologie , Uretère/malformations , Obstruction urétérale/complications , Femelle , Humains , Nouveau-né , Rein/imagerie diagnostique , Rein/chirurgie , Maladies du rein/chirurgie , Radiographie thoracique , Insuffisance respiratoire/imagerie diagnostique , Échographie , Uretère/chirurgie , Obstruction urétérale/étiologie , Urographie
20.
Horm Metab Res ; 42(12): 831-6, 2010 Nov.
Article de Anglais | MEDLINE | ID: mdl-20803413

RÉSUMÉ

Macrophage-secreted factors inhibit adipogenesis, but the underlying mechanism is not well understood. Our objective was to determine if anti-adipogenic signaling pathways in human preadipocytes are activated by macrophage-conditioned medium (MacCM). Human abdominal subcutaneous stromal preadipocytes were treated with adipogenic inducers in either standard medium or medium conditioned by human THP-1 macrophages. THP-1-MacCM increased inhibitor of κB kinase ß (IKKß) phosphorylation, inhibitor of NF-κB α (IκBα) degradation, and NF-κB activity in human preadipocytes in a time-dependent manner. Concomitant treatment of human abdominal subcutaneous preadipocytes with sc-514, a selective inhibitor of IKKß, prevented the inhibitory effect of THP-1-MacCM on lipid accumulation and expression of adipogenic markers. Our data indicate that activation of the preadipocyte IKKß/NF-κB pathway is required for the anti-adipogenic effect of THP-1-MacCM on human adipogenesis.


Sujet(s)
Adipocytes/métabolisme , Adipogenèse , Milieux de culture conditionnés/métabolisme , I-kappa B Kinase/métabolisme , Protéines I-kappa B/métabolisme , Macrophages/métabolisme , Facteur de transcription NF-kappa B/métabolisme , Transduction du signal , Adipocytes/cytologie , Adipocytes/effets des médicaments et des substances chimiques , Adipogenèse/effets des médicaments et des substances chimiques , Adulte , Lignée cellulaire , Cellules cultivées , Milieux de culture conditionnés/pharmacologie , Femelle , Humains , I-kappa B Kinase/génétique , Protéines I-kappa B/génétique , Adulte d'âge moyen , Inhibiteur alpha de NF-KappaB , Facteur de transcription NF-kappa B/génétique , Phosphorylation , Transduction du signal/effets des médicaments et des substances chimiques
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE